AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study

AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.